2 No-Brainer Stocks to Buy Right Now for Less than $1,000
These tech leaders will grow even stronger over the next decade, and your retirement savings will reap the rewards.
Mindfully Curated
These tech leaders will grow even stronger over the next decade, and your retirement savings will reap the rewards.
Walmart is a mature company, but it’s still targeting some huge growth niches.
It could be time for some other AI stocks to carry the market higher.
Has Novo Nordisk’s already red-hot stock become an even better buy?
Are these stocks too expensive to invest in?
Intel and Micron eagerly await the rebounding replacement cycle for personal computers.
The fast-food chain’s shares are priced at a discount right now.
These stocks have been providing excellent returns for a long time.
Looking for explosive opportunities in today’s bull market? These beaten-down stocks could soar.
It is important to know what each AI company does.
This ETF can provide investors with market-beating potential and more stability than your typical growth-focused ETF.
A price target of $3,300 might seem ambitious, but the data suggests it’s well within reach.
On this episode of FYI, hosts Nemo Marjanovic and Charles Roberts speak with Professor Dr. Michael Snyder, a leading figure in genomics and personalized medicine.
These industry leaders have been around for a long time and continue to outperform expectations.
The market still has plenty of value stocks available.
The company might enter the hottest segment in the pharmaceutical sphere before long.
The online pet supplies retailer posts mixed financial results, but better days are ahead.
Investing in this company 10 years ago would have produced excellent returns, but it’s not too late — far from it.
On this episode of FYI, hosts Nemo Marjanovic and Charles Roberts speak with Professor Dr. Michael Snyder, a leading figure in genomics and personalized medicine.
A cross-disciplinary team has developed a new contact lens material that could act as a bandage for corneal wounds while releasing drugs in a controlled manner to help the eye heal faster.